ResearcherTabriz University of Medical SciencesNo recent work listed
Darya Javadrashid
Matched on ORCID iD 0000-0001-5220-6463; OpenAlex author ID A5007304898. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2021: 3 papers
Papers 3
- Envisioning the immune system to determine its role in pancreatic ductal adenocarcinoma: Culprit or victim? Co-author DOI 10.1016/j.imlet.2021.02.009↗
- Simultaneous microRNA-612 restoration and 5-FU treatment inhibit the growth and migration of human PANC-1 pancreatic cancer cells. Co-author DOI 10.17179/excli2020-2900↗
- Pancreatic Cancer Signaling Pathways, Genetic Alterations, and Tumor Microenvironment: The Barriers Affecting the Method of Treatment. Co-author DOI 10.3390/biomedicines9040373↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Behzad Baradaran · 3 shared papers, 2021 · strength 0.42
- Paper Envisioning the immune system to determine its role in pancreatic ductal adenocarcinoma: Culprit or victim? DOI 10.1016/j.imlet.2021.02.009↗
- Paper Pancreatic Cancer Signaling Pathways, Genetic Alterations, and Tumor Microenvironment: The Barriers Affecting the Metho… DOI 10.3390/biomedicines9040373↗
- Paper Simultaneous microRNA-612 restoration and 5-FU treatment inhibit the growth and migration of human PANC-1 pancreatic ca… DOI 10.17179/excli2020-2900↗
- Ziba Lotfi · 2 shared papers, 2021 · strength 0.28
- Paper Envisioning the immune system to determine its role in pancreatic ductal adenocarcinoma: Culprit or victim? DOI 10.1016/j.imlet.2021.02.009↗
- Paper Simultaneous microRNA-612 restoration and 5-FU treatment inhibit the growth and migration of human PANC-1 pancreatic ca… DOI 10.17179/excli2020-2900↗
- Antonio Giovanni Solimando · 1 shared paper, 2021 · strength 0.14
- Afshin Derakhshani · 1 shared paper, 2021 · strength 0.14
- Vito Racanelli · 1 shared paper, 2021 · strength 0.14
- Nicola Silvestris · 1 shared paper, 2021 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.